NDC 49502-500-01 - EPIPEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49502-500
- Requested NDC
- 49502-500-01
- Package NDCs from labels
- 49502-500-01, 49502-500-02, 49502-500-92
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-02-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| EPIPEN - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-02-15 | HUMAN PRESCRIPTION DRUG LABEL |
| EPIPEN - Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 2023-08-29 | HUMAN PRESCRIPTION DRUG LABEL |
| EPIPEN - Viatris Specialty LLC | Viatris Specialty LLC | 2023-02-15 | HUMAN PRESCRIPTION DRUG LABEL |
| EPINEPHRINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2022-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| EPIPEN - TYA Pharmaceuticals | TYA Pharmaceuticals | 2014-05-01 | HUMAN PRESCRIPTION DRUG LABEL |
| EpiPen - Dispensing Solutions, Inc. | PSS World Medical, Inc. | Dispensing Solutions, Inc. | PSS World Medical, Inc. | 2012-09-25 | HUMAN PRESCRIPTION DRUG LABEL |
| EpiPen - Physicians Total Care, Inc. | Physicians Total Care, Inc. | 2012-05-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49502-500-01 | EPIPEN | 0.3 mL in 1 SYRINGE, GLASS | INJECTION | 0.3 | 37 | |
| 49502-500-01 | EPIPEN | 1 in 1 CONTAINER | INJECTION | 1 | 37 | |
| 49502-500-02 | EPIPEN | 2 in 1 CARTON | INJECTION | 2 | 37 | |
| 49502-500-92 | EPIPEN | 2 in 1 CARTON | INJECTION | 2 | 37 | |
| 49502-500-92 | EPIPEN | 1 in 1 CONTAINER | INJECTION | 1 | 37 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49502-500-01 | EA - Each | 49502-500 | b7a3a225-9ccd-4d53-a858-8a284a69d257 | 1 | 2022-09-12 |
| 49502-500-02 | EA - Each | 49502-500 | 942cabcc-475f-4c52-a017-9960981c7d24 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SALINE NASAL | SODIUM CHLORIDE | ALAINA HEALTHCARE PRIVATE LIMITED | ed30a7f9-7132-42da-9bed-63a9b1c80ab2 | 2026-07-07 | Warnings | 451W47IQ8X |
| Epinephrine | EPINEPHRINE | A-S Medication Solutions | 386519ba-7a44-4edd-9eb1-748419b7a71b | 2026-07-06 | Warnings, Adverse reactions | YKH834O4BH |
| Dr. Drop NMN Vital Balance (Drop No.1 Cream 90g) | NMN (NICOTINAMIDE MONONUCLEOTIDE), ECTOIN (ECTOINE) | Reedfresh Co., LTD | 55d703ca-ff9d-0dbc-e063-6294a90ab6b1 | 2026-07-05 | Warnings | 059QF0KO0R |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Protective Industrial Products, Inc. | 558e5926-9027-d3f6-e063-6294a90ab121 | 2026-07-02 | Warnings | 059QF0KO0R |
| Fendall 2000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a1d07e-0006-0c75-e063-6394a90a7acc | 2026-07-02 | Warnings | 059QF0KO0R |
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-07-02 | Warnings | 059QF0KO0R |
| Sterile Eyesaline Eyewash | STERILE EYESALINE EYEWASH | Protective Industrial Products, Inc. | 55a290e8-8310-8be4-e063-6394a90abdce | 2026-07-02 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Protective Industrial Products, Inc. | 55a261c2-725d-6765-e063-6294a90a3260 | 2026-07-02 | Warnings | 059QF0KO0R |
| Remodulin | TREPROSTINIL | United Therapeutics Corporation | 6c80bb38-e8db-4138-9f0d-dbbf9c673185 | 2026-07-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Adrenalin | EPINEPHRINE | Par Health USA, LLC | 3b7a4364-668d-4eb2-a20c-04adc35aabe4 | 2026-07-01 | Warnings, Adverse reactions | YKH834O4BH |
| The Cell Salt Co. Daily Blend 12 in 1 | CALC FLUOR, CALC PHOS, CALC SULPH, FERRUM PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT MUR, NAT PHOS, NAT SULPH, SILICEA | The Cell Salt Company LLC | 55826f59-acf4-7370-e063-6394a90afed7 | 2026-07-01 | Warnings | 451W47IQ8X |
| NebuClear MD Saline | NEBUCLEAR MD SALINE | Blue Echo Care LLC | 55820ff9-7b4b-2bce-e063-6394a90a8b43 | 2026-06-30 | Warnings | 451W47IQ8X |
| NebuClear MD Saline | NEBUCLEAR MD SALINE | Blue Echo Care LLC | 55806cb8-cf92-c4e5-e063-6394a90aaa2d | 2026-06-30 | Warnings | 451W47IQ8X |
| NebuClear MD Saline | NEBUCLEAR MD SALINE | Blue Echo Care LLC | 5581d8e5-4105-e9da-e063-6394a90a316e | 2026-06-30 | Warnings | 451W47IQ8X |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 76176d50-a987-c9f9-e053-2991aa0aea0f | 2026-06-29 | Warnings, Adverse reactions | YKH834O4BH |
| Fendall 2000 Pure Flow | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37dead3e-60cb-88ae-e063-6294a90a8f70 | 2026-06-24 | Warnings | 059QF0KO0R |
| MCAS Support | APIS MELLIFICA, ANTIMONIUM CRUDUM, ASCORBICUM ACIDUM, BOVISTA, CARBOLICUM ACIDUM, CHAMOMILLA, CORTISONE ACETICUM, GINKGO BILOBA, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, NATRUM MURIATICUM, QUERCETIN, RHUS TOX, SCUTELLARIA LATERIFLORA, STOMACH (SUIS), URTICA URENS | Deseret Biologicals, Inc. | af3d5f8f-6f24-4045-8730-c776ff54bcc4 | 2026-06-24 | Warnings | 451W47IQ8X |
| Bacteriostatic Water | BACTERIOSTATIC WATER | Fujian Genohope Biotech Ltd. | 54f66b82-c9e5-a2bc-e063-6394a90adbbc | 2026-06-23 | 059QF0KO0R | |
| LIDOCAINE HCl AND EPINEPHRINE | LIDOCAINE HCL AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | a09613b2-4337-5b52-e053-2995a90ab74b | 2026-06-19 | Warnings, Adverse reactions | YKH834O4BH |
| Nitrogen | NITROGEN | Maine Oxy-Acetylene Supply Company | 652ecc66-c6bb-40a3-a12f-64c7a4cdaca8 | 2026-06-18 | N762921K75 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.